Phylogenetic relationships of


Journal

Frontiers in cellular and infection microbiology
ISSN: 2235-2988
Titre abrégé: Front Cell Infect Microbiol
Pays: Switzerland
ID NLM: 101585359

Informations de publication

Date de publication:
2023
Historique:
received: 08 02 2023
accepted: 28 02 2023
medline: 4 4 2023
entrez: 3 4 2023
pubmed: 4 4 2023
Statut: epublish

Résumé

The epidemiological situation of tuberculosis (TB) in Poland urges for its continuous and scrupulous monitoring. The objective of this study was to explore the genetic diversity of multidrug-resistant (MDR) and drug-susceptible (DS) The study included 89 (39 MDR and 50 DS) The main identified families were Beijing (28.1%) and Haarlem (16.8%) while 34.8% of isolates were in the heterogeneous L4-unclassified group. Although the Beijing family was the most prevalent (61.5%) among MDR-TB cases, it accounted for only 2% of DS isolates. Among foreign-born patients, a higher ratio of MDR isolates were observed when compared with those who Poland-born (64.3% vs. 40%). Furthermore, all patients from the Former Soviet Union (FSU) countries were infected with MDR-TB. Whereas DS

Identifiants

pubmed: 37009494
doi: 10.3389/fcimb.2023.1161905
pmc: PMC10061152
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1161905

Informations de copyright

Copyright © 2023 Bakuła, Marczak, Bluszcz, Proboszcz, Kościuch, Krenke, Stakėnas, Mokrousov and Jagielski.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

J Clin Microbiol. 2011 Dec;49(12):4173-8
pubmed: 21998434
Microbes Infect. 2010 Jun;12(6):467-75
pubmed: 20215000
J Clin Microbiol. 2008 Aug;46(8):2692-9
pubmed: 18550737
Clin Microbiol Infect. 2014 Nov;20(11):1134-9
pubmed: 24944074
J Clin Microbiol. 2010 Oct;48(10):3544-50
pubmed: 20702677
Int J Tuberc Lung Dis. 2011 Sep;15(9):1252-8, i
pubmed: 21943854
Int J Mycobacteriol. 2019 Jan-Mar;8(1):60-69
pubmed: 30860181
J Clin Microbiol. 2006 Dec;44(12):4498-510
pubmed: 17005759
Microbiol Spectr. 2016 Aug;4(4):
pubmed: 27726798
Eur J Clin Microbiol Infect Dis. 2015 Jan;34(1):41-53
pubmed: 25037868
BMC Genomics. 2018 Oct 22;19(1):762
pubmed: 30348088
mBio. 2013 Jul 30;4(4):
pubmed: 23900170
Sci Rep. 2021 Nov 1;11(1):21392
pubmed: 34725411
Sci Rep. 2017 Aug 23;7(1):9227
pubmed: 28835627
Pathogens. 2019 Jun 10;8(2):
pubmed: 31185670
PLoS One. 2016 Apr 29;11(4):e0153580
pubmed: 27128522
Diagnostics (Basel). 2022 Aug 03;12(8):
pubmed: 36010233
PLoS One. 2016 Mar 03;11(3):e0149435
pubmed: 26939051
Emerg Microbes Infect. 2020 Dec;9(1):1342-1353
pubmed: 32538300
Nat Commun. 2014 Sep 01;5:4812
pubmed: 25176035
J Clin Microbiol. 1997 Apr;35(4):907-14
pubmed: 9157152
Epidemiol Mikrobiol Imunol. 2019 Winter;68(3):131-136
pubmed: 31914778
Antimicrob Agents Chemother. 2006 Aug;50(8):2820-3
pubmed: 16870777
Infect Genet Evol. 2020 Mar;78:104126
pubmed: 31783188
Diagn Microbiol Infect Dis. 2006 May;55(1):59-64
pubmed: 16490334
J Bacteriol. 2014 May;196(10):1833-41
pubmed: 24584500
Nat Genet. 2015 Mar;47(3):242-9
pubmed: 25599400
Tuberculosis (Edinb). 2014 Jul;94(4):434-40
pubmed: 24888866
Immunol Rev. 2015 Mar;264(1):6-24
pubmed: 25703549
Emerg Infect Dis. 2020 Mar;26(3):481-490
pubmed: 32091369
PLoS One. 2017 Feb 21;12(2):e0172554
pubmed: 28222189
BMC Res Notes. 2013 Dec 28;6:561
pubmed: 24373461
Iran J Microbiol. 2017 Dec;9(6):312-317
pubmed: 29487728
FEMS Immunol Med Microbiol. 2009 Jan;55(1):13-22
pubmed: 18801045
Diagnostics (Basel). 2021 Sep 26;11(10):
pubmed: 34679466
J Clin Microbiol. 2010 Nov;48(11):3899-909
pubmed: 20810763
Pol Arch Med Wewn. 2016;126(1-2):32-40
pubmed: 26842376
Pol J Microbiol. 2015;64(4):399-401
pubmed: 26999963
Clin Microbiol Infect. 2017 Dec;23(12):1002-1004
pubmed: 28698038
J Clin Microbiol. 1988 Nov;26(11):2465-6
pubmed: 3069867
PLoS One. 2013 Jun 24;8(6):e65873
pubmed: 23826083
Int J Mycobacteriol. 2013 Dec;2(4):194-8
pubmed: 26786121
BMC Infect Dis. 2011 Mar 28;11:77
pubmed: 21439097
Mol Phylogenet Evol. 2017 Nov;116:202-212
pubmed: 28893611
PLoS Med. 2022 Feb 22;19(2):e1003933
pubmed: 35192619
Microorganisms. 2023 Jan 19;11(2):
pubmed: 36838219
Respir Med. 2019 May;151:19-26
pubmed: 31047113

Auteurs

Zofia Bakuła (Z)

Department of Medical Microbiology, Institute of Microbiology, University of Warsaw, Faculty of Biology, Warsaw, Poland.

Mateusz Marczak (M)

Department of Medical Microbiology, Institute of Microbiology, University of Warsaw, Faculty of Biology, Warsaw, Poland.

Agata Bluszcz (A)

Department of Medical Microbiology, Institute of Microbiology, University of Warsaw, Faculty of Biology, Warsaw, Poland.

Małgorzata Proboszcz (M)

Department of Internal Medicine, Pulmonary Diseases & Allergy, Medical University of Warsaw, Warsaw, Poland.

Justyna Kościuch (J)

Department of Internal Medicine, Pulmonary Diseases & Allergy, Medical University of Warsaw, Warsaw, Poland.

Rafał Krenke (R)

Department of Internal Medicine, Pulmonary Diseases & Allergy, Medical University of Warsaw, Warsaw, Poland.

Petras Stakėnas (P)

Department of Immunology and Cell Biology, Institute of Biotechnology, Life Sciences Center, Vilnius University, Vilnius, Lithuania.

Igor Mokrousov (I)

Laboratory of Molecular Epidemiology and Evolutionary Genetics, St. Petersburg Pasteur Institute, St. Petersburg, Russia.
Henan International Joint Laboratory of Children's Infectious Diseases, Henan Children's Hospital, Zhengzhou Children's Hospital, Zhengzhou, China.

Tomasz Jagielski (T)

Department of Medical Microbiology, Institute of Microbiology, University of Warsaw, Faculty of Biology, Warsaw, Poland.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH